My Quote Request
6505-01-096-2734
20 Products
NDC50111-0471-01
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010962734
NSN
6505-01-096-2734
NDC50111-0471-01
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010962734
NSN
6505-01-096-2734
MFG
PLIVA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS PROPRANOLOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPRANOLOL HYDROCHLORIDE TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PERCODAN
OXYCODONE AND ASPIRIN TABLETS,USP
NSN, MFG P/N
6505010958570
NSN
6505-01-095-8570
PERCODAN
OXYCODONE AND ASPIRIN TABLETS,USP
NSN, MFG P/N
6505010958570
NSN
6505-01-095-8570
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 4.500 MILLIGRAMS OXYCODONE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.380 MILLIGRAMS OXYCODONE TEREPHTHALATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MYLANTA
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
MYLANTA
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
MFG
MCNEIL CONSUMER PRODUCTS CO HOSPITAL REGIONAL OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED PER MILLILITER AND 40.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER MILLILITER AND 4.000 MILLIGRAMS DIMETHICONE PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINUM HYDROXIDE GEL MAGNESIUM HYDROXIDE & SIMETHICONE SUSPENSION 30ML 100S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MCNEIL LABS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 10 CUPS,UNIT DOSE
PRIMARY CONTAINER TYPE: CUP,UNIT DOSE
SECONDARY CONTAINER TYPE: TRAY
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
MYLANTA SUSPENSION
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
MYLANTA SUSPENSION
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
MFG
MCNEIL CONSUMER PRODUCTS CO HOSPITAL REGIONAL OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED PER MILLILITER AND 40.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER MILLILITER AND 4.000 MILLIGRAMS DIMETHICONE PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINUM HYDROXIDE GEL MAGNESIUM HYDROXIDE & SIMETHICONE SUSPENSION 30ML 100S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MCNEIL LABS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 10 CUPS,UNIT DOSE
PRIMARY CONTAINER TYPE: CUP,UNIT DOSE
SECONDARY CONTAINER TYPE: TRAY
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
NDC00038-0610-23
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
NDC00038-0610-23
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED PER MILLILITER AND 40.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER MILLILITER AND 4.000 MILLIGRAMS DIMETHICONE PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINUM HYDROXIDE GEL MAGNESIUM HYDROXIDE & SIMETHICONE SUSPENSION 30ML 100S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MCNEIL LABS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 10 CUPS,UNIT DOSE
PRIMARY CONTAINER TYPE: CUP,UNIT DOSE
SECONDARY CONTAINER TYPE: TRAY
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
NDC00045-0610-23
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
NDC00045-0610-23
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED PER MILLILITER AND 40.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER MILLILITER AND 4.000 MILLIGRAMS DIMETHICONE PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINUM HYDROXIDE GEL MAGNESIUM HYDROXIDE & SIMETHICONE SUSPENSION 30ML 100S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MCNEIL LABS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 10 CUPS,UNIT DOSE
PRIMARY CONTAINER TYPE: CUP,UNIT DOSE
SECONDARY CONTAINER TYPE: TRAY
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
NDC16837-0610-23
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
NDC16837-0610-23
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010959185
NSN
6505-01-095-9185
MFG
MCNEIL CONSUMER PRODUCTS CO HOSPITAL REGIONAL OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED PER MILLILITER AND 40.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER MILLILITER AND 4.000 MILLIGRAMS DIMETHICONE PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINUM HYDROXIDE GEL MAGNESIUM HYDROXIDE & SIMETHICONE SUSPENSION 30ML 100S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MCNEIL LABS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 10 CUPS,UNIT DOSE
PRIMARY CONTAINER TYPE: CUP,UNIT DOSE
SECONDARY CONTAINER TYPE: TRAY
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
14243
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 20MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LASIX
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 20MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00039-0067-70
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
NDC00039-0067-70
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 20MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00054-4297-31
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
NDC00054-4297-31
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 20MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1170-10
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
NDC00182-1170-10
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 20MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00364-0568-02
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
NDC00364-0568-02
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 20MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00536-3840-10
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
NDC00536-3840-10
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010960621
NSN
6505-01-096-0621
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 20MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ATIVAN
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010960623
NSN
6505-01-096-0623
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00008-0081-02
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010960623
NSN
6505-01-096-0623
NDC00008-0081-02
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010960623
NSN
6505-01-096-0623
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00536-3959-01
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010960623
NSN
6505-01-096-0623
NDC00536-3959-01
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010960623
NSN
6505-01-096-0623
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
08-8356-1
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505010960626
NSN
6505-01-096-0626
08-8356-1
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505010960626
NSN
6505-01-096-0626
MFG
HERMES CONSOLIDATED INC. DBA WYOMING REFINING COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 102.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 135.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 38.000 MILLIEQUIVALENTS ACETATE ION PER LITER AND 0.500
PRIMARY CONTAINER CONTENT QUANTITY: 3430.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: MILLIEQUIVALENTS MAGNESIUM ION PER LITER AND 1.000 MILLIEQUIVALENTS POTASSIUM ION PER LITER
Related Searches:
ERI-LYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505010960626
NSN
6505-01-096-0626
ERI-LYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505010960626
NSN
6505-01-096-0626
MFG
HERMES CONSOLIDATED INC. DBA WYOMING REFINING COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 102.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 135.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 38.000 MILLIEQUIVALENTS ACETATE ION PER LITER AND 0.500
PRIMARY CONTAINER CONTENT QUANTITY: 3430.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: MILLIEQUIVALENTS MAGNESIUM ION PER LITER AND 1.000 MILLIEQUIVALENTS POTASSIUM ION PER LITER
Related Searches:
NDC00536-4316-01
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010962734
NSN
6505-01-096-2734
NDC00536-4316-01
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010962734
NSN
6505-01-096-2734
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS PROPRANOLOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPRANOLOL HYDROCHLORIDE TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE